Publications by authors named "Angelo Fama"

Claim this Profile
D
Diagnostic and therapeutic pathways for lymphoma patients: expert consensus through Nominal Group Technique and Delphi methodology.
Attilio Guarini, Valentina Bozzoli, Sabino Ciavarella, Michele Cimminiello, Francesca Donatelli, Angelo Fama

Front Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The complexity of pharmaceutical expenditures across U.S. states.
Lisa Cross, Angelo Famà, Paolo Pagnottoni, Nicolò Pecora, Alessandro Spelta

Sci Rep· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of first-line treatment with bendamustine plus rituximab versus R-CHOP for patients with follicular lymphoma grade 3A: Results of a retrospective study from the Fondazione Italiana Linfomi.
Gloria Margiotta-Casaluci, Sara Bigliardi, Federica Cocito, Erika Meli, Luigi Petrucci, Angelo Fama

Front Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electronic case report forms generation from pathology reports by ARGO, automatic record generator for onco-hematology.
Gian Maria Zaccaria, Vito Colella, Simona Colucci, Felice Clemente, Fabio Pavone, Angelo Fama

Sci Rep· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathologic Characteristics, Treatment, and Outcomes of Post-transplant Lymphoproliferative Disorders: A Single-institution Experience Using 2017 WHO Diagnostic Criteria.
Rebecca L King, Arushi Khurana, Raphael Mwangi, Angelo Fama, Kay M Ristow

Hemasphere· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of intrafollicular memory CD4 + T cells is predictive of early clinical failure in newly diagnosed follicular lymphoma.
Patrizia Mondello, Angelo Fama, Melissa C Larson, Andrew L Feldman, Jose C Villasboas

Blood Cancer J· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SFLT-1 levels in COVID-19 patients: Association with outcome and thrombosis.
Aurelio Negro, Angelo Fama, Domenico Penna, Lucia Belloni, Alessandro Zerbini

Am J Hematol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human Pegivirus Infection and Lymphoma Risk: A Systematic Review and Meta-analysis.
Angelo Fama, Melissa C Larson, Brian K Link, Thomas M Habermann, Andrew L Feldman

Clin Infect Dis· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Texture analysis and multiple-instance learning for the classification of malignant lymphomas.
Marco Lippi, Stefania Gianotti, Angelo Fama, Massimiliano Casali, Elisa Barbolini

Comput Methods Programs Biomed· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Gene Expression-based Model to Predict Metabolic Response After Two Courses of ABVD in Hodgkin Lymphoma Patients.
Stefano Luminari, Benedetta Donati, Massimiliano Casali, Riccardo Valli, Raffaella Santi, Angelo Fama

Clin Cancer Res· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MYC Rearranged Aggressive B-Cell Lymphomas: A Report on 100 Patients of the Fondazione Italiana Linfomi (FIL).
Maria Chiara Tisi, Simone Ferrero, Irene Dogliotti, Cristina Tecchio, Giuseppe Carli, Angelo Fama

Hemasphere· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide in Pretreated Patients with Diffuse Large B-Cell Lymphoma: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice.
Alessandro Broccoli, Beatrice Casadei, Annalisa Chiappella, Carlo Visco, Monica Tani, Angelo Fama

Oncologist· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice (the Lenamant Study).
Vittorio Stefoni, Cinzia Pellegrini, Alessandro Broccoli, Luca Baldini, Monica Tani, Angelo Fama

Oncologist· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human Pegivirus infection and lymphoma risk and prognosis: a North American study.
Angelo Fama, Jinhua Xiang, Brian K Link, Cristine Allmer, Donna Klinzman

Br J Haematol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Comparison of the Conditioning Regimens BEAM and FEAM for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: An Observational Study on 1038 Patients From Fondazione Italiana Linfomi.
Jacopo Olivieri, Federico Mosna, Matteo Pelosini, Angelo Fama, Sara Rattotti

Biol Blood Marrow Transplant· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of JAK2 -positive essential thrombocythaemia and early primary myelofibrosis: The impact of mutation burden and histology.
Roberto Latagliata, Nicola Polverelli, Alessia Tieghi, Giuseppe Alberto Palumbo, Massimo Breccia, Angelo Fama

Hematol Oncol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Italian real-life experience with brentuximab vedotin: results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma.
Alessandro Broccoli, Cinzia Pellegrini, Alice Di Rocco, Benedetta Puccini, Caterina Patti, Angelo Fama

Haematologica· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Italian real life experience with brentuximab vedotin: results of a large observational study on 234 relapsed/refractory Hodgkin's lymphoma.
Cinzia Pellegrini, Alessandro Broccoli, Alessandro Pulsoni, Luigi Rigacci, Caterina Patti, Angelo Fama

Oncotarget· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The chronic lymphocytic leukemia international prognostic index predicts time to first treatment in early CLL: Independent validation in a prospective cohort of early stage patients.
Stefano Molica, Tait D Shanafelt, Diana Giannarelli, Massimo Gentile, Rosanna Mirabelli

Am J Hematol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Catheter-associated bloodstream infections and thrombotic risk in hematologic patients with peripherally inserted central catheters (PICC).
Salvatore Giacomo Morano, Roberto Latagliata, Corrado Girmenia, Fulvio Massaro, Paola Berneschi, Angelo Fama

Support Care Cancer· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anagrelide treatment and cardiovascular monitoring in essential thrombocythemia. A prospective observational study.
Giovanni Tortorella, Andrea Piccin, Alessia Tieghi, Luigi Marcheselli, Michael Steurer, Angelo Fama

Leuk Res· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive geriatric assessment is an essential tool to support treatment decisions in elderly patients with diffuse large B-cell lymphoma: a prospective multicenter evaluation in 173 patients by the Lymphoma Italian Foundation (FIL).
Alessandra Tucci, Maurizio Martelli, Luigi Rigacci, Paola Riccomagno, Maria Giuseppina Cabras, Angelo Fama

Leuk Lymphoma· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atypical presentation of anaplastic large T-cell lymphoma mimicking an articular relapse of rheumatoid arthritis in a patient treated with etanercept. A case report and literature review.
Federico De Angelis, Alice Di Rocco, Clara Minotti, Guido Valesini, Claudio Cartoni, Angelo Fama

Leuk Res· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decisional flow with a scoring system to start platelet-lowering treatment in patients with essential thrombocythemia: long-term results.
Roberto Latagliata, Angela Rago, Antonio Spadea, Cristina Santoro, Ida Carmosino, Angelo Fama

Int J Hematol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platelet count is an independent prognostic factor in myelodysplastic syndromes considered as low risk by French-American-British and World Health Organisation classifications.
Massimo Breccia, Gianna Maria D'Elia, Laura Cannella, Caterina Stefanizzi, Angelo Fama

Leuk Lymphoma· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis